Partner of Choice. By Choice.

In 2022 Inpart surveyed more than 100 biotechs worldwide for its Partnering 2030 report​ to determine which pharma company offered the very best partnering experience. The clear winner: AbbVie. Praised by biotechs for its good working relationships and commitment to achieving business and scientific objectives, AbbVie has established itself as a partner of choice – and it’s not by accident. ​

In this exclusive webinar, Niels Emmerich, Vice President and Global Head of Search & Evaluation, explains how AbbVie chose to position itself as a partner of choice for biotechs, the best practices it implemented to achieve this position, and what the company is seeking in partners in 2023 and beyond.​ ​

Watch the replay to learn:​

• How important the 'first touch' is in biopharma partnering​
• Effective strategies for getting your foot in the door at a top pharma company
• What partnering opportunities AbbVie is seeking in 2023​

Watch this replay to get expert insights from our panelists:

Niels Emmerich

Vice President, Global Head S&E at AbbVie

Caroline Toulemonde

Chief Operating Officer at Inpart